Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW) "CMB-NOW"

Active, not recruiting

Phase N/A Results N/A

Summary of Purpose

Anticoagulants are generally recognized as a necessary therapy to prevent the recurrence of ischemic stroke in patients with non-valvular atrial fibrillation (NVAF), but in some patients they also cause bleedings, particularly intracranial hemorrhage. One of the independent predictors of intracerebral hemorrhage is the presence of cerebral microbleeds (CMBs); a high incidence of intracerebral hemorrhage is...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 October 2016.

1 Mar 2015 1 Feb 2015 1 Sep 2016 1 Sep 2017 1 Oct 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Contacts